Last updated: 22 Jan 2023
10.21608/mid.2021.71677.1142
antimalarial, antibiotic, Pharmacy, COVID-19, Nigeria
Rasheed
Makanjuola
Osuolale
Department of Biology and Biotechnology, University of Pavia, Lombardy, Italy. Department of Microbiology, Nasarawa State University, Keffi, Nigeria
rasheedosuolal.makanjuola01@universitadipavia.it
Pavia
0000-0002-1908-3438
Adebayo
Bello
Ajibola
Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria
a.bello@ibadanu.edu
Ibadan
Fawziyyah
Sadiq
Department of Microbiology and Biotechnology, Nile University, Abuja, Nigeria
f.u.sadiq@yahoo.com
Abuja
David
Ishaleku
Department of Mathematics, Nasarawa State University, Keffi, Nigeria
d.ishaleku@nsu.ed.net
Keffi
Kehinde
Oduwole
Henry
Department of Mathematics, Nasarawa State University, Keffi, Nigeria
k.oduwole@nsu.ed.net
Keffi
Andrew
Taylor-Robinson
School of Health, Medical and Applied Sciences, Central Queensland University, Brisbane, Australia. College of Health and Human Sciences, Charles Darwin University, Casuarina, Australia.
a.taylor-robinson@cqu.edu.au
Brisbane
0000-0001-7342-8348
2
3
26240
2021-08-01
2021-03-09
2021-08-01
423
432
2682-4132
2682-4140
https://mid.journals.ekb.eg/article_168120.html
https://mid.journals.ekb.eg/service?article_code=168120
7
Original Article
1,157
Journal
Microbes and Infectious Diseases
https://mid.journals.ekb.eg/
Details
Type
Article
Created At
22 Jan 2023